Vertex Pharmaceuticals (VRTX) Insider Trading & Ownership $434.31 -2.27 (-0.52%) Closing price 05/19/2026 04:00 PM EasternExtended Trading$438.34 +4.02 (+0.93%) As of 08:37 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Vertex Pharmaceuticals (NASDAQ:VRTX) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage0.20%Number OfInsiders Buying(Last 12 Months)1Amount OfInsider Buying(Last 12 Months)$1.95MNumber OfInsiders Selling(Last 12 Months)12Amount OfInsider Selling(Last 12 Months)$115.48M Get VRTX Insider Trade Alerts Want to know when executives and insiders are buying or selling Vertex Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Subscribe Now View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. VRTX Insider Buying and Selling by Quarter Vertex Pharmaceuticals Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame Start Date End Date Export Transaction DateInsiderBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails5/12/2026Carmen BozicCMOSell6,988$450.00$3,144,600.00 5/4/2026Sangeeta N BhatiaDirectorSell318$423.73$134,746.14 5/1/2026Joy LiuEVPSell1,104$425.02$469,222.08 4/1/2026Joy LiuEVPSell978$449.17$439,288.26 3/13/2026Carmen BozicCMOSell2,329$481.79$1,122,088.91 2/25/2026Amit SachdevEVPSell1,846$486.35$897,802.10 2/25/2026Duncan MckechnieEVPSell4,910$487.65$2,394,361.50 2/25/2026Edward Morrow Atkinson IIIEVPSell668$486.35$324,881.80 2/25/2026Jonathan BillerEVPSell945$486.35$459,600.75 2/25/2026Kristen AmbroseCAOSell223$486.35$108,456.05 This Biotech Just Flipped From Story to Execution (Ad)Avai Bio (OTCQB: AVAI) has moved into production on its new Master Cell Bank, developed alongside Austrianova, advancing its alpha-Klotho program toward scalable, potentially commercial therapy. AVAI sits at the intersection of longevity science, regenerative medicine, and cell therapy - targeting multiple high-value conditions tied to aging and chronic disease. This is early-stage positioning before momentum becomes obvious.Discover how AVAI is targeting a multi-billion-dollar shift in disease treatment2/25/2026Mark E BunnageEVPSell620$486.35$301,537.00 2/25/2026Ourania TatsisEVPSell260$486.35$126,451.00 2/19/2026Amit SachdevEVPSell58,613$468.83$27,479,532.79 2/13/2026Ourania TatsisEVPSell1,500$499.99$749,985.00 2/11/2026Edward Morrow Atkinson IIIEVPSell1,751$460.43$806,212.93 2/11/2026Jonathan BillerEVPSell1,925$460.43$886,327.75 2/11/2026Kristen AmbroseCAOSell1,376$460.43$633,551.68 2/11/2026Mark E BunnageEVPSell2,021$460.43$930,529.03 2/11/2026Ourania TatsisEVPSell466$460.43$214,560.38 1/29/2026David TaylorHouse (R-OH)Sell$475.68$1,001 - $15,0001/7/2026Ourania TatsisEVPSell4,500$474.99$2,137,455.00 1/6/2026Charles F Wagner JrEVPSell9,532$461.00$4,394,252.00 12/3/2025Charles F Wagner JrEVPSell14,000$456.00$6,384,000.00 12/3/2025Jeffrey M LeidenChairmanSell63,781$449.20$28,650,425.20 11/14/2025Jeffrey M LeidenChairmanSell53,604$440.72$23,624,354.88 11/13/2025Jeffrey M LeidenChairmanSell19,688$440.27$8,668,035.76 8/7/2025David TaylorHouse (R-OH)Buy$375.63$1,001 - $15,0008/6/2025Bruce I SachsDirectorBuy5,000$389.68$1,948,400.00 (Data available from 1/1/2013 forward) VRTX Insider Trading Activity - Frequently Asked Questions Who is on Vertex Pharmaceuticals' Insider Roster? The list of insiders at Vertex Pharmaceuticals includes Amit Sachdev, Bruce I Sachs, Carmen Bozic, Charles F Wagner Jr, David Altshuler, Duncan Mckechnie, Edward Morrow Atkinson III, Jeffrey M Leiden, Jonathan Biller, Joy Liu, Kristen Ambrose, Mark E Bunnage, Ourania Tatsis, Reshma Kewalramani, Sangeeta N Bhatia, and Stuart A Arbuckle. Learn more on insiders at VRTX. What percentage of Vertex Pharmaceuticals stock is owned by insiders? 0.20% of Vertex Pharmaceuticals stock is owned by insiders. Learn more on VRTX's insider holdings. Which Vertex Pharmaceuticals insiders have been buying company stock? The following insider purchased VRTX shares in the last 24 months: Bruce I Sachs ($1,948,400.00). How much insider buying is happening at Vertex Pharmaceuticals? Insiders have purchased a total of 5,000 VRTX shares in the last 24 months for a total of $1,948,400.00 bought. Which Vertex Pharmaceuticals insiders have been selling company stock? The following insiders have sold VRTX shares in the last 24 months: Amit Sachdev ($28,377,334.89), Bruce I Sachs ($5,858,564.00), Carmen Bozic ($10,759,741.31), Charles F Wagner Jr ($12,256,319.50), David Altshuler ($1,644,762.28), Duncan Mckechnie ($2,394,361.50), Edward Morrow Atkinson III ($4,614,758.73), Jeffrey M Leiden ($62,831,031.84), Jonathan Biller ($1,345,928.50), Joy Liu ($908,510.34), Kristen Ambrose ($742,007.73), Mark E Bunnage ($1,232,066.03), Ourania Tatsis ($4,765,872.02), Reshma Kewalramani ($8,270,599.00), and Sangeeta N Bhatia ($457,746.14). How much insider selling is happening at Vertex Pharmaceuticals? Insiders have sold a total of 318,461 Vertex Pharmaceuticals shares in the last 24 months for a total of $146,459,603.81 sold. Which members of congress are trading Vertex Pharmaceuticals? David Taylor (R-OH) has bought shares of Vertex Pharmaceuticals in the last year totaling $8,000. David Taylor (R-OH) and Lisa C. McClain (R-MI) have sold shares totaling $24,000. Vertex Pharmaceuticals Active InsidersReshma Kewalramani (Age 53)CEOMark E BunnageExecutive Vice President and Chief Scientific Officer2 recent tradesDuncan MckechnieExecutive Vice President and Chief Commercial Officer1 recent tradesStuart A Arbuckle (Age 60)COOIan F SmithCOOCharles F Wagner Jr (Age 58)CFO2 recent tradesJeffrey M Leiden (Age 69)Chairman1 recent tradesPaul M SilvaCAOKristen Ambrose (Age 49)CAO2 recent tradesJoshua S Boger (Age 75)DirectorSangeeta N. BhatiaDirector1 recent tradesMargaret G McglynnDirectorYuchun LeeDirectorBruce I SachsDirectorBastiano SannaEVPAmit SachdevEVP2 recent tradesDavid Altshuler (Age 60)EVPOurania TatsisEVP4 recent tradesMichael Parini (Age 50)EVPJonathan Biller (Age 62)EVP2 recent tradesEdward Morrow Atkinson IIIEVP2 recent tradesJoy LiuSVP2 recent tradesDr. Reshma Kewalramani FASNM.D.Carmen BozicCMO2 recent trades More Insider Trading Tools from MarketBeat Related Companies Amazon.com Insider Selling Axsome Therapeutics Insider Selling CRISPR Therapeutics Insider Selling Alphabet Insider Selling Intuitive Surgical Insider Selling Moderna Insider Selling Repligen Insider Selling AbbVie Insider Selling Eli Lilly and Company Insider Selling Pfizer Insider Selling Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Latest Articles 3 Dividend Stocks With Insiders Buying in 2026Insider Buying Says Upstart Isn’t Down for the CountInsider Trades: Okta and Abbott See Buys, Micron Insiders SellMarketBeat Week in Review – 05/04 - 05/08BlackBerry Rewrites Its Own Operating System This page (NASDAQ:VRTX) was last updated on 5/20/2026 by MarketBeat.com Staff. From Our PartnersTrump's gold order: the announcement they won't put on the front pageOn August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...Reagan Gold Group | SponsoredHey, it's Jon Najarian. The SpaceX IPO is right around the corner. But I discovered Elon may have something BIGGER planned. Check this out before June 9th...After being invited to the SpaceX launch headquarters in Cape Canaveral from one of Elon's top lobbyists… Hall...Banyan Hill Publishing | SponsoredI’m sounding the alarmMeta is cutting 10% of its workforce. Microsoft offered voluntary retirement to 7% of U.S. employees. Oracle, ...Porter & Company | SponsoredIran's New Leader Just Said Something That Should Terrify Every AmericanIran's Supreme Leader has declared the Strait of Hormuz closed as leverage against the U.S. - and with 40% of ...American Alternative | SponsoredYour book attachedVeteran trader Bill Poulos is giving away his 'Simple Options Trading For Beginners' book - normally $29.97 - ...Profits Run | SponsoredThis Biotech Just Flipped From Story to ExecutionAvai Bio (OTCQB: AVAI) has moved into production on its new Master Cell Bank, developed alongside Austrianova,...Equiscreen | SponsoredDistracted Americans set to miss out on quadrillionsTechnology expert and Washington D.C. insider Jeff Brown - who identified Bitcoin, Tesla, and Nvidia early - s...Brownstone Research | SponsoredSpaceX just filed. The clock is ticking.Reuters reports Elon Musk filed secretly. Barron's says it's being finalized behind closed doors. CNBC just re...The Oxford Club | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Vertex Pharmaceuticals Incorporated Please log in to your account or sign up in order to add this asset to your watchlist. Share Vertex Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
